Literature DB >> 955835

An explanation for the long duration of mydriatic effect of atropine in eye.

M Salazar, P N Patil.   

Abstract

The mydriatic effect of topically applied 3H-atropine (2%) was compared in the pigmented rabbits (black fur and dark brown irides) and nonpigmented (albino) atropinesterase-negative rabbits. The duration, t1/2, of the mydriatic effect in the nonpigmented and pigmented rabbit was 43.5 and greater than 96 hours, respectively. At hour 96, the tissue 3H-atropine in the pigmented iris was greater than that in the nonpigmented iris by the factor of eight. The longer duration of mydriatic effect in the pigmented iris is explained by the slow release of the bound drug from the pigment onto the muscarinic receptors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 955835

Source DB:  PubMed          Journal:  Invest Ophthalmol        ISSN: 0020-9988


  6 in total

1.  The extraneuronal uptake and metabolism of 3H-isoprenaline in the rabbit iris.

Authors:  P N Patil; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

2.  Binding of betaxolol, metoprolol and oligonucleotides to synthetic and bovine ocular melanin, and prediction of drug binding to melanin in human choroid-retinal pigment epithelium.

Authors:  Leena Pitkänen; Veli-Pekka Ranta; Hanna Moilanen; Arto Urtti
Journal:  Pharm Res       Date:  2007-06-02       Impact factor: 4.200

3.  A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells.

Authors:  Yoo Chun Kim; Henry T Hsueh; Matthew D Shin; Cynthia A Berlinicke; Hyounkoo Han; Nicole M Anders; Avelina Hemingway; Kirby T Leo; Renee Ti Chou; HyeYoung Kwon; Matthew B Appell; Usha Rai; Patricia Kolodziejski; Charles Eberhart; Ian Pitha; Donald J Zack; Justin Hanes; Laura M Ensign
Journal:  Drug Deliv Transl Res       Date:  2021-04-26       Impact factor: 4.617

Review 4.  Peptidomimetics Therapeutics for Retinal Disease.

Authors:  Dylan E Parsons; Soo Hyeon Lee; Young Joo Sun; Gabriel Velez; Alexander G Bassuk; Mark Smith; Vinit B Mahajan
Journal:  Biomolecules       Date:  2021-02-24

5.  Characterization of artificially re-pigmented ARPE-19 retinal pigment epithelial cell model.

Authors:  Laura Hellinen; Marja Hagström; Heidi Knuutila; Marika Ruponen; Arto Urtti; Mika Reinisalo
Journal:  Sci Rep       Date:  2019-09-24       Impact factor: 4.379

6.  Corneal Penetration of Low-Dose Atropine Eye Drops.

Authors:  Henning Austermann; Frank Schaeffel; Ute Mathis; Verena Hund; Frank Mußhoff; Focke Ziemssen; Sven Schnichels
Journal:  J Clin Med       Date:  2021-02-04       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.